闭孔神经阻滞在多模式镇痛下全髋关节置换术中不提供镇痛益处:一项随机对照试验
该单中心前瞻性三盲随机对照试验纳入60例在无阿片类药物全静脉全身麻醉下接受全髋关节置换术的患者,比较术前闭孔神经阻滞与安慰剂阻滞。主要结局为麻醉后监护室静脉阿片类药物消耗量,闭孔神经阻滞组中位4(2, 7.5)mg,安慰剂组3(0, 4)mg(p=0.05)。结论认为在多模式镇痛方案下,闭孔神经阻滞未改善全髋关节置换术后阿片类药物消耗。
要点
- 闭孔神经阻滞未减少全髋关节置换术后麻醉后监护室静脉阿片类药物消耗。
- 除到达外科病房时安慰剂组疼痛评分显著更高外,术后24小时内两组疼痛评分无差异。
- 两组术后24小时内站立和行走能力及首次行走时间相当。
核心结论
- 在全身麻醉联合多模式镇痛方案下,闭孔神经阻滞未改善全髋关节置换术后阿片类药物消耗。
研究设计与样本
- 单中心、前瞻性、三盲随机对照试验,纳入60例在无阿片类药物全静脉全身麻醉下接受全髋关节置换术的患者。
- 患者随机接受术前闭孔神经阻滞(20 mL罗哌卡因0.2%)或安慰剂阻滞(20 mL生理盐水)。
- 所有患者均接受包括关节周围局部浸润镇痛在内的多模式非阿片类镇痛方案。
主要发现
- 麻醉后监护室静脉羟考酮消耗量中位数(IQR):闭孔神经阻滞组4(2, 7.5)mg,安慰剂组3(0, 4)mg(p=0.05)。
- 术后24小时内两组疼痛评分无差异,唯一例外是到达外科病房时安慰剂组疼痛评分显著更高(p=0.03)。
- 两组术后24小时内站立和行走能力相当,首次行走时间闭孔神经阻滞组180(90, 720)min,安慰剂组240(120, 780)min(p=0.62)。
临床怎么用
- 在全髋关节置换术多模式镇痛方案下,不应常规添加闭孔神经阻滞以期望减少术后阿片类药物消耗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Although regional analgesia is considered an important component of optimal pain management, use of peripheral nerve blocks for total hip arthroplasty remains controversial. Since the obturator nerve innervates the anteromedial part of the joint capsule, we hypothesized that an obturator nerve block would decrease the opioid consumption after total hip arthroplasty. METHODS: In this single center, prospective, triple blinded study, we randomly allocated 60 patients undergoing total hip arthroplasty under opioid-sparing total intravenous general anesthesia to a preoperative obturator nerve block or a sham block (placebo group) using 20 mL of ropivacaine 0.2% or saline, respectively. All patients received a multimodal analgesic regimen with non-opioid analgesics including periarticular local infiltration analgesia. The primary outcome was the intravenous opioid consumption in the post-anesthesia care unit. RESULTS: Median (IQR) intravenous oxycodone consumption in the post-anesthesia care unit was 4 (2, 7.5) mg in the obturator nerve block group and 3 (0, 4) mg in the placebo group (p=0.05). There were no differences in pain scores between groups in the first 24 hours except at arrival on the surgical ward with significant higher pain scores in the placebo group (p=0.03). The ability to stand up and walk within 24 hours was comparable between groups as was the time to first walk (180 (90, 720) vs 240 (120, 780) min for the obturator nerve block and placebo groups, respectively; p=0.62). CONCLUSIONS: Obturator nerve block did not improve postoperative opioid consumption after total hip arthroplasty performed under general anesthesia with a multimodal analgesic regimen. TRIAL REGISTRATION NUMBER: NCT04085640.
引用
- Marty P, Chassery C, Rontes O, et al. Obturator nerve block does not provide analgesic benefits in total hip arthroplasty under multimodal analgesic regimen: a randomized controlled trial. Reg Anesth Pain Med. 2021. PMID: 33952684. doi:10.1136/rapm-2021-102531
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。